Welcome Customer !

Membership

Help

Suzhou Qianshe Biotechnology Co., Ltd
Custom manufacturer

Main Products:

instrumentb2b>Products
Product Categories

Suzhou Qianshe Biotechnology Co., Ltd

  • E-mail

  • Phone

  • Address

    1355 Greenland Avenue, Suzhou City, Jiangsu Province

Contact Now

PAN fetal bovine serum ST30-3302

NegotiableUpdate on 05/06
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin

Overview

PAN fetal bovine serum ST30-3302 | Spot supply $r $n Our company's main products are domestic passaging cell lines and cell culture related biological reagents. GIBCO、HyClone、NTC、SIGMA、 Israeli BI, GEMINI, PAN, German Cegrogen, SERANA, and SBI serums without extracellular vesicles. Conventional liquid culture medium, dual antibody, serum-free cryopreservation solution, Mitsubishi products from Japan, ELISA kits, Sigma spot reagents and other products. After sales *, we warmly welcome new and old customers to choose with full enthusiasm!

Product Details

PANFetal Bovine SerumST30-3302

Brand:PAN

Item No.ST30-3302

Specifications500ml

Suzhou Qianshe Biotechnology has been focusing on biological reagents for many years, PAN ST30-3302, ST30-2602, ST30-3302P... More product numbers are available for sale and in stock supply!

PAN胎牛血清ST30-3302


PAN胎牛血清ST30-3302



Brand Introduction:

GermanyPAN-Biotech GmbHEstablished in1988Year, headquartered in Edenbach, Bavaria, Germany(Adenbach), is a biotechnology enterprise specializing in cell culture related products.

PAN-BiotechMainly producing serum, culture medium, and cell culture related reagents;PAN SystechMainly engaged in the production and manufacturing of automated cell culture instruments.

Like other German brands, it has high-quality products made in Germany, and its entire line of products holds a considerable share in developed countries in Europe and America.

PANAll products produced by the company arecGMPProduced under production conditions, the product has been approved by the European Medicines Agency(EDQM)Certified and hasISO134852012andISO90012008Quality certification.

GermanyPANThe company's premium fetal bovine serum is a premium series selected through strict process screening, with strict quality control, small inter batch differences, good quality stability, low endotoxin content, no virus or mycoplasma, and high safety. Cell culture tests have shown that multiple cell lines exhibit better growth characteristics and are suitable for a wide variety of cell cultures.
GermanyPANDetailed description of fetal bovine serum:
1)Very low endotoxin content<1UI/mlInternational regulations: Premium fetal bovine serum<10 UI/ml)Extremely beneficial for cell growth and passage
2)Having the European Medicines Agency(EDQM)The product certificate issued complies with the European Pharmacopoeia1483Regulations
3GMPProduced under conditions with a quality certification system certificate
4)Each batch of serum has a complete test report
5)Three times0.01 μmAseptic filtration treatment
6)Conduct bacterial, mycoplasma, virus, and virus antibody testing in accordance with the requirements of the International Animal Federation
7)Can be used according to customer requirementsγRadiation exposure


In the field of cell culture, many researchers struggle with a question when using serum:Should it be heat inactivated or not?

especially forFetal bovine serum(FBSThis is calledThe golden nutrient solution for cellsSome laboratories follow old habits and habitually use them56℃heat treatment30minute, in order toInactivated complement.

But today, we want to talk to everyone aboutFrom the perspective of developmental immunologyLet's clarify a conclusion:

For high-qualityFetal Bovine SerumMost experimentsNo longer requiring thermal inactivation treatment

01What is the complement system?

The complement system is present in both humans and animalsInnate immune systemAn important component of, consisting of30Multiple plasma protein compositions. These proteins can:

·Directly damaging the cell membrane and inducing dissolution;

·Attract immune cells and amplify inflammatory responses;

·Cooperate with antibodies to clear antigens.

However, this complementAttack Power, inCell culture systemIt is often ainterfering factorEspecially forImmune cells or stem cellsThey are very sensitive to complement, ranging from poor condition to direct death in severe cases.

02Complement development in fetal cattle

Many people don't know,Fetal cow(fetal bovine)Not an immune mature individual.

From the perspective of embryonic development:

Complement components

synthesis time

Mature functionality

C3/C4/C5

Approximately gestational age3-4Starting to express in months

Extremely low expression level, immature function

Complement terminal complex(MAC

Weak expression ability during pregnancy

Complete formation ability is only acquired after birth

Regulatory factors (such as factors)H

Limited expression

Gradually upregulated after birth

Overall complement activity

Below adult cattle10–20%

Gradual enhancement after birth

let me put it another way:The complement in fetal bovine serum is naturally low and has weak activity, lacking true cell killing ability.

03Heat inactivation may actually have the opposite effect?

The traditional heat inactivation operation isin56°Cwater bath30minuteUsed to destroy complement proteins.

But this step also has side effects:

degradedValuable growth factors and cytokines

Increase protein aggregation and form precipitates;

The increase in inter batch differences affects the reproducibility of the experiment;

Shorten the shelf life and activity window of serum.

For modern technology preparationFBSproductDoing heat inactivation again is actually a methodpass

Why was cell culture used in the pastDo you want heat inactivated serum?

2010Before the year, the serum used for cell culture in China was mainly newborn bovine serum, with very little fetal bovine serum. With the large-scale slaughter of beef cattle, fetal bovine serum raw materials began to appear, gradually replacing newborn bovine serum. Therefore, in the era of newborn bovine serum, heat inactivation has a certain significance, and many laboratories have also developed a habit.

05What are the exceptions? Can still be thermally inactivated!

Although not necessary in most cases, in the following special situations,Heat inactivation still makes sense

Conduct complement dependent cytotoxicity experiments(CDC)The control group;

Cultivate primary cells that are highly sensitive to complement, such asPBMC

In some animal experiments, to exclude complement variables;

It is known that a certain batch of serum contains trace residual complement activity (determined by detection or pre-test).

PANFetal Bovine SerumST30-3302|Qianshe Biotechnology Hot Selling Cells

WS60087 HCCC-9810 Human cholangiocarcinoma cells

WS60088 HCCLM3 Human highly metastatic liver cancer cells

WS60089 HCT 116 human colon cancer cell

WS60090 HCT-8 Human ileocecal cancer cells

WS60091 HEC-1-A Human endometrial adenocarcinoma cells

WS60092 HEC-1-BHEC-1B Human endometrial adenocarcinoma cells

WS60093 293 HK293 Human embryonic kidney cells

WS60094 HEL Human erythroleukemia cells

WS60095 Hela Human cervical cancer cells

WS60096 Hela-S3 Hela-Jcell

WS60097 Hep G2 Human liver cancer cells

WS60099 Hep3B2.1-7 Human liver cancer cells

WS60100 HEY Human ovarian cancer cells

WS60101 HFL1 Human embryonic lung fibroblasts

WS60103 HFOB1.19 personSV40Transfection of osteoblasts

WS60104 HGC-27 Human gastric cancer cells(Undifferentiated)

WS60105 HK-2 Epithelial cells of human renal cortex proximal tubules

WS60106 HL-60 Human myeloid leukemia cells

WS60107 HMEC-1 Human microvascular endothelial cells

WS60108 HO-8910 Human ovarian cancer cells

WS60109 hTERT-HPNE Human pancreatic ductal cells

WS60110 HS 683 Human brain optic glioma cells

WS60112 HT-1080 Human fibrosarcoma cells

WS60113 HT-29 human colon cancer cell

WS60114 HT-3 Human cervical cancer cells

WS60115 HTR-8/Svneo Human embryonic nourishing cells

WS60116 HuCCT1 Cholangiocarcinoma cells

WS60117 HuH-6 Human hepatoblastoma cells

WS60118 HuH-7 Human liver cancer cells

WS60119 HuT 78 personTLymphocytic leukemia cells

WS60120 HUVEC Immortalization of human umbilical vein endothelial cells

WS60121 KLE Human endometrial cancer cells

WS60122 JAR Human placental villous carcinoma cells

WS60123 JEG-3 Human choriocarcinoma cells

WS60124 JeKo-1 Human mantle cell lymphoma cells

WS60125 Jurkat, Clone E6-1 personTLymphocytic leukemia cells

WS60126 K-562 Human chronic myeloid leukemia cells

WS60127 KATO III Human gastric cancer cells

WS60129 KTC-1 Human thyroid cancer cells

WS60130 7= Human peripheral blood basophilic leukemia cells

WS60131 KYSE-150 Human esophageal cancer cells

WS60132 Li-7 Human liver cancer cells

WS60133 LNCaP clone FGC Human prostate cancer cells

WS60134 L02HL7702 Normal human liver cells

WS60135 LoVo human colon cancer cell

WS60136 LS 174T Human colon adenocarcinoma cells

WS60137 MCF 10A Normal human breast epithelial cells

WS60138 MCF7 Human breast cancer cells

WS60139 MDA-MB-231 Human breast cancer cells

WS60140 AD293 Human embryonic kidney cells

WS60141 LX-2 Human hepatic stellate cells

WS60142 MDA-MB-436 Human breast cancer cells

WS60143 MDA-MB-468 Human breast cancer cells

WS60144 MG-63 Human osteosarcoma cells

WS60145 MGC-803 Human gastric cancer cells

WS60146 MIA Paca2 MIA Paca2cell

WS60147 MM.1S MM.1Scell

WS60148 MNNG/HOS CL #5 MNNG/HOS CL #5cell

WS60149 MRC-5 Human embryonic lung cells

WS60150 MV4-11 Human acute monocytic leukemia cells

WS60152 NCI-H1299 Human non-small cell lung cancer cells

WS60153 NCI-H1563 Human embryonic lung cells

WS60154 NCI-H2452 Human skin tumor cells

WS60155 NCI-H647 Human non-small cell lung cancer cells

WS60156 NK-92MI Natural Killer Cells in Human Malignant Non Hodgkin's Lymphoma Patients

WS60157 Nthy-ori 3-1 Normal cells of human thyroid gland

WS60159 OS-RC-2 Human renal cancer cells

WS60160 OVCAR-3 Human ovarian cancer cells

WS60161 PANC-1 Human pancreatic cancer cells

WS60162 PC-3 Human prostate cancer cells

WS60163 PC-3M Human prostate cancer cells

WS60164 PC-9 Human prostate cancer cells

WS60165 PLC-PRF-5 Human liver cancer Alexander cells

WS60166 Raji personBurkitt'sLymphoma cells

WS60167 RBE Human cholangiocarcinoma cells

WS60168 RD Human malignant embryonic rhabdomyoma cells

WS60169 RKO Human colon adenocarcinoma cells

WS60170 RL95-2RL-95-2 Human endometrial cancer cells

WS60171 RT4 Human bladder transitional cell papilloma cells

WS60172 RWPE-1 Normal prostate epithelial cells in humans

WS60173 SAOS - 2 Human osteosarcoma cells

WS60174 SH-SY5Y Human neuroblastoma cells

WS60175 SiHa Human cervical squamous cell carcinoma cells

WS60176 SJCRH30 Human bone marrow striated muscle cancer cells

WS60177 SK-BR-3 Human breast adenocarcinoma cells

WS60178 SK-HEP-1 Human liver cancer cells

WS60179 SK-MES-1 Human lung squamous cell carcinoma cells

WS60180 SK-N-BE(2) Human neuroblastoma cells

WS60181 SK-NEP-1 Human nephroblastoma cells

WS60182 SK-N-SH Human neuroblastoma cells

WS60183 NB 4 Acute promyelocytic leukemia cells

WS60184 AsPC-1 Human metastasis of pancreatic adenocarcinoma cells

WS60185 SU-DHL-6 personBlymphocyte

WS60186 SV-HUC-1 Immortalized human ureteral epithelial cells

WS60187 SW1990 Human pancreatic cancer cells

WS60188 SW1353 Human osteosarcoma cells

WS60189 SW480 human colon cancer cell

WS60190 SW579 Human thyroid squamous cell carcinoma cells

WS60191 SW620 human colon cancer cell

WS60192 SW837 Human colorectal adenocarcinoma cells

WS60193 SW982 Human synovial sarcoma cells

WS60194 T/G HA-VSMC Human vascular smooth muscle cells

WS60195 T-24 Human bladder transitional cell carcinoma cells

WS60196 T47DT-47D Human breast ductal carcinoma cells

WS60198 T84 Human colon adenocarcinoma lung metastasis cells

WS60199 WSU-HN6Human tongue squamous cell carcinoma cells Human tongue squamous cell carcinoma cells

WS60201 TE-1 Human esophageal cancer cells

WS60202 THP-1 Human monocytic leukemia

WS60204 TPC-1 Human thyroid cancer cells

WS60205 TT Human thyroid ductal carcinoma cells

WS60206 TTA1 Human thyroid cancer cells

WS60207 U-118MG Human brain astrocytes

WS60208 U-2 OS Human osteosarcoma cells

WS60209 U251 Human glioma cells

WS60210 U-87MG Human glioblastoma cells

WS60211 U-937 Human histiocytic lymphoma cells

WS60212 UM-UC-3 Human bladder transitional cell carcinoma

WS60213 VCAP Human prostate cancer cells

WS60214 WERI-RB-1 Human retinal glioma cells

WS60215 WI-38 Human embryonic lung cells

WS60217 WPMY-1 Immortal cells in normal prostate stroma

WS60218 ZR-75-1 Human breast cancer cells

WS60219 ZR-75-30 Human breast cancer cells

WS60220 AAV293 Human embryonic kidney cells

WS60221 NCI-N87N87 Gastric cancer cells

WS60222 SW1116 Human colon adenocarcinoma cells

WS60223 293A Human embryonic kidney cells

WS60224 HNE1 Human nasopharyngeal carcinoma cells

WS60225 SKOV3SK-OV-3 Human ovarian cancer cells

WS60226 SGC-7901/5-FU Human gastric adenocarcinoma cell resistance5-FUstrain

WS60227 Hep3BHep3B2.1-7 Human liver cancer cells

WS60228 Ishikawa Human endometrial cancer cells

WS60229 Eca-109 Human esophageal cancer cells

WS60230 H1 Human embryonic stem cells

WS60231 HESHuman embryonic stem cells Human embryonic stem cells

WS60232 H9Human embryonic stem cells Human embryonic stem cells

WS60233 HC-aHuman articular chondrocytes Human articular chondrocytes (identified by immunofluorescence)

WS60239 NCI-H2228 Human non-small cell lung cancer cells

WS60241 NCI-H1437 Human lung cancer cells

WS60242 HOS Human osteosarcoma cells

WS60243 Hela S3 Human cervical cancer cells

WS60244 J.gamma1 Acute humanTCell leukemiaTcell

WS60246 Het-1a Human esophageal epithelial cells(SV40bigTAntigen transfection)

WS60247 Hela Human cervical cancer cells

WS60248 SUP-B15 personPh+Acute lymphoblastic leukemia cell line

WS60249 AMO-1 Human plasma cell myeloma cells

WS60250 CAOV3 Human ovarian adenocarcinoma cells

WS60251 TF-1 Human blood leukemia cells

WS60252 HUVEC Human umbilical vein endothelial cells

WS60253 A2780/DDP Human ovarian cancer cellsDDPdrug-resistant strain

WS60254 HFF-1 Human skin fibroblasts

WS60255 MCF7/Taxol Human breast cancer taxol resistant strain

WS60256 U87mg Astrocytoma of the human brain

WS60257 NCI-H929 Human plasma cell leukemia cells

WS60258 Hela/DDP Human cervical cancer cellsDDPdrug-resistant strain

WS60259 A2780/DDP Human ovarian cancer resistanceDDPcell

WS60260 NIH-3T3cell

WS60261 IEC-6cell

WS60262 IOSE80cell